昭衍新药
(603127)
| 流通市值：233.61亿 | | | 总市值：277.71亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-02-11 | -2595.52万 | -7.23% | -1636.16万 | -4.56% | 494.26万 | 1.38% | 3737.42万 | 10.41% |
| 2026-02-10 | 220.97万 | 0.59% | -544.07万 | -1.46% | -1037.58万 | -2.79% | 1360.68万 | 3.66% |
| 2026-02-09 | -2898.63万 | -8.45% | -1413.36万 | -4.12% | -146.48万 | -0.43% | 4458.48万 | 12.99% |
| 2026-02-06 | 1033.18万 | 1.92% | 1481.83万 | 2.75% | -1070.46万 | -1.99% | -1444.55万 | -2.68% |
| 2026-02-05 | -751.64万 | -2.19% | 928.42万 | 2.70% | 1047.98万 | 3.05% | -1224.76万 | -3.56% |
| 2026-02-04 | -891.10万 | -2.48% | 2626.04万 | 7.32% | 384.54万 | 1.07% | -2119.48万 | -5.91% |
| 2026-02-03 | 625.35万 | 1.15% | 2492.99万 | 4.59% | -1530.15万 | -2.82% | -1588.18万 | -2.93% |
| 2026-02-02 | -3249.28万 | -5.16% | -2985.79万 | -4.75% | -5256.08万 | -8.35% | 11491.14万 | 18.26% |
| 2026-01-30 | 3824.14万 | 6.91% | 227.91万 | 0.41% | 1223.03万 | 2.21% | -5275.08万 | -9.53% |
| 2026-01-29 | -784.80万 | -1.45% | -1513.20万 | -2.80% | -2339.04万 | -4.33% | 4637.03万 | 8.59% |